Conclusions Our study confirmed the benefit of sequential anthracycline-taxane chemotherapy in node positive breast cancer in the real-world albeit with higher toxicity.doi:10.1093/annonc/mdz338.050Nisha ShariffWan Zamaniah Binti Wan IshakAnnals of Oncology...
Chemotherapy in patients with anthracycline and taxane-pretreated metastatic breast cancer: an overview. Curr Breast Cancer Rep. 2013;5(1):42-50.Eleni Andreopoulou,Joseph A. Sparano.  Chemotherapy in Patients with Anthracycline and Taxane-Pretreated Metastatic Breast Cancer: An Overview[J]. ...
Neoadjuvant bevacizumab 和在 678 三倍消极最初乳腺癌中的 anthracycline-taxane-基于的化疗;由于 geparquinto 研究 (GBG 44)。 翻译结果3复制译文编辑译文朗读译文返回顶部 新辅助贝伐单抗和基于蒽环类药物-紫杉烷类化疗的 678 三阴性乳腺癌癌症 ;geparquinto 研究 (全球 44) 的结果。 翻译结果4复制译文编辑译文...
Prolonged Disease Control in a Patient With Anthracycline- and Taxane-Resistant Breast Cancer 来自 掌桥科研 喜欢 0 阅读量: 49 作者:CA Castaneda,HL Gómez 摘要: Resistance to chemotherapy is a complex and very frequent problem in the treatment of breast cancer. It is associated with a poor ...
We aimed to better characterise the benefits and risks of including anthracycline, and the comparative benefits of different anthracycline–taxane regimens. 背景 与不化疗相比,用于早期乳腺癌的蒽环类-紫杉烷类化疗显着提高了生存率。 然而,由于对蒽环类药物的短期和长期副作用的担忧,导致越来越多地使用不含...
A chi-square test was used to compare the incidence and relative risk of short side effects with both anthracycline and taxane-containing regimens. Results The average age of participants was 49.1 years. In both regimens, the findings highlighted the frequency and relative risk of the following ...
Our results suggest that the addition of durvalumab to anthracycline-/taxane-based NACT increases pCR rate particularly in patients treated with durvalumab alone before start of chemotherapy. Trial registration ClinicalTrials.gov number: NCT02685059.Previous...
Objective : To compare clinical and economic study data for docetaxel, paclitaxel and vinorelbine in the treatment of anthracycline-resistant advanced brea... DRE Brown,J Hutton,A Burrell - 《Pharmacoeconomics》 被引量: 249发表: 2001年 Anthracycline- and/or taxane-resistant breast cancer: Results ...
A case of anthracycline and taxane-resistant breast cancer with life-thereatening multiple liver metastases responding to oral combination chemotherapy by ... A case of anthracycline and taxane-resistant breast cancer with life-thereatening multiple liver metastases responding to oral combination chemother...
aCisplatin-ifosfamide combination chemotherapy in metastatic triple-negative, anthracycline- and taxane-pretreated breast cancer patients; a phase II study. Cisplatin-ifosfamide组合化疗在变形的三倍消极, anthracycline-和taxane被预处理的乳腺癌患者; 阶段II研究。[translate]...